Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Capital City Bank Group (CCBG) - free report >>
Immunocore Holdings PLC Sponsored ADR (IMCR) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Capital City Bank Group (CCBG) - free report >>
Immunocore Holdings PLC Sponsored ADR (IMCR) - free report >>
Image: Bigstock
Best Momentum Stocks to Buy for July 12th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 12th:
Capital City Bank Group, Inc. (CCBG - Free Report) : This financial holding company for Capital City Bank has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.1% over the last 60 days.
Capital City Bank Group Price and Consensus
Capital City Bank Group price-consensus-chart | Capital City Bank Group Quote
Capital City’ shares gained 11.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of B.
Capital City Bank Group Price
Capital City Bank Group price | Capital City Bank Group Quote
Immunocore Holdings plc (IMCR - Free Report) : This late-stage biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.4% over the last 60 days.
Immunocore Holdings PLC Sponsored ADR Price and Consensus
Immunocore Holdings PLC Sponsored ADR price-consensus-chart | Immunocore Holdings PLC Sponsored ADR Quote
Immunocore’s shares gained 12.5% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.
Immunocore Holdings PLC Sponsored ADR Price
Immunocore Holdings PLC Sponsored ADR price | Immunocore Holdings PLC Sponsored ADR Quote
F-star Therapeutics, Inc. : This clinical-stage biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.3% over the last 60 days.
Fstar Therapeutics, Inc. Price and Consensus
Fstar Therapeutics, Inc. price-consensus-chart | Fstar Therapeutics, Inc. Quote
F-star’s shares gained 86.8% over the last three months compared with the S&P 500’s decline of 12.2%. The company possesses a Momentum Score of A.
Fstar Therapeutics, Inc. Price
Fstar Therapeutics, Inc. price | Fstar Therapeutics, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.